Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Finland Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20022
20033
20046
20055
20064
20075
20088
20097
20109
20118
20122
20133
20141
20152
20163
20172
20182
20201
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Terminated12
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S22
AstraZeneca17
Boehringer Ingelheim12
Sanofi9
Novartis Pharmaceuticals3
Takeda3
Bayer2
Eli Lilly and Company2
GlaxoSmithKline2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 284
Diabetes Mellitus33
Glucose Metabolism Disorders4
Obesity4
Cardiovascular Diseases3
Hypertension3
Metabolic Diseases3
Diabetic Nephropathies2
Endocrine System Diseases2
Heart Failure2

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.